About Genetic Technologies Limited (GNTLF) — Dividend Analysis 2026
Genetic Technologies Limited, a molecular diagnostics company, provides predictive testing and assessment tools to help physicians manage women's health in Australia and the United States. The company's lead product is the BREVAGenplus, a clinically validated risk assessment test for non-hereditary breast cancer. It also markets BREVAGenplus to healthcare professionals in breast health care and imaging centers, as well as to obstetricians/gynecologists and breast cancer risk assessment specialists, such as breast surgeons. In addition, the company offers various cancer risk assessment tests under the GeneType for Colorectal Cancer and GeneType for Breast Cancer brand names; and develops other risk assessment tests across a range of diseases, which include cardiovascular, type 2 diabetes, prostate cancer, and melanoma. Further, it offers genetic testing services, including medical, animal, forensic, and plant testing. The company has research and collaboration agreements with the University of Melbourne, Translational Genomics Research Institute, Memorial Sloan Kettering New York Cambridge University, the Ohio State University, and Shivom. Genetic Technologies Limited was incorporated in 1987 and is headquartered in Fitzroy, Australia.
Is GNTLF a good dividend investment in 2026?
GNTLF offers a 200.00% forward yield with a 50% payout ratio. Strand Safety Score: 0/100 (Critical Risk). The 5-year dividend CAGR of 0% is modest — investors should weigh current income against growth alternatives.
GNTLF DRIP calculator — what's the difference?
With DRIP on a $10,000 investment over 10 years, your GNTLF portfolio grows to $48.73M vs $10.44M without reinvestment. This is the compound interest effect in action.
GNTLF dividend growth history & forecast
GNTLF has grown its dividend by 0% over the last year and 0% annually over 5 years. At this pace, an investor who holds for 10+ years will see their yield on cost grow substantially above the current 200.00%.
Company generates negative FCF ($-10M) — borrowing to pay dividends
Debt Leverage0.0× Debt/EBITDA
0 / 30 pts
0/30
Company not generating EBITDA — debt servicing risk is elevated
Earnings Momentum-0.0B → -0.0B → -0.0B
0 / 30 pts
0/30
Company is reporting net losses — dividend sustainability is in question
OVERALL ASSESSMENT
High risk of dividend cut — weak fundamentals across multiple factors.
STRAND SCORE
0
/100
Strand Safety Score™ is proprietary to DividendFlow. Inputs: FCF, Debt/EBITDA, Net Income from SEC filings via FMP. Not financial advice. N/A for ETFs, pre-revenue companies, and tickers without income statements.
🌍 GNTLF Yield by Country & Account Type
Real after-tax yield depends on where you live and how you hold GNTLF.
Gross yield
200.00%
Tax rate
15.00%
After-tax yield
170.00%
Real yield (−CPI)
167.20%
Account/Country
Tax Rate
After-tax Yield
Real Yield
$10K Annual Income
🇺🇸 Roth IRA / 401k
0%
200.00%
197.20%
$20,000 / yr
🇺🇸 US Taxable (15%) ✓
15%
170.00%
167.20%
$17,000 / yr
🇺🇸 US Taxable (20%)
20%
160.00%
157.20%
$16,000 / yr
🇬🇧 UK ISA
0%
200.00%
197.20%
$20,000 / yr
🇬🇧 UK Taxable
8.75%
182.50%
179.70%
$18,250 / yr
🇨🇦 TFSA
0%
200.00%
197.20%
$20,000 / yr
🇨🇦 CA Taxable
25%
150.00%
147.20%
$15,000 / yr
🇦🇺 Super (pension)
15%
170.00%
167.20%
$17,000 / yr
🇦🇺 AU Taxable
30%
140.00%
137.20%
$14,000 / yr
🇩🇪 DE Taxable
26.375%
147.25%
144.45%
$14,725 / yr
🇫🇷 FR Taxable
30%
140.00%
137.20%
$14,000 / yr
Real yield = after-tax yield minus US CPI of 2.8%. 12-month CPI (US BLS via FMP economic-indicators). Click any row to select. US withholding tax (30%, reducible by treaty) applies to non-US residents holding US stocks in taxable accounts.
🎯 GNTLF Income Goal & Break-Even
Dividend Break-Even
1yr
Years for dividends to fully repay your GNTLF investment of $1.00/share (🇺🇸 US Taxable (15%) · 15.00% tax)
$10K invested · 10 Years
Dividends earned (DRIP)
$534.7K
Lost to inflation (2.8% CPI)
−$2.5K
Real purchasing power gain
$532.2K
12-month CPI (US BLS via FMP economic-indicators).
How much do I need to invest in GNTLF for:
Shares needed
14,118
Capital required
$14,118
Monthly income
$2,000
Based on current dividend of $2.00/share/yr · 🇺🇸 US Taxable (15%) · static projection (no growth assumed).
📅 GNTLF Dividend Payment Schedule
GNTLF pays quarterly — 4 times per year. Next ex-div: TBD.
Jan
Feb
Mar
💰
Apr
May
Jun
💰
Jul
Aug
Sep
💰
Oct
Nov
Dec
💰
10 shares
$4.25 / payment
$17.00 / year after tax
100 shares
$42.50 / payment
$170.00 / year after tax
1,000 shares
$425.00 / payment
$1700.00 / year after tax
📊 GNTLF vs Healthcare Benchmarks
How GNTLF compares to typical Healthcare averages.
Benchmark: Healthcare
Dividend Yield▲+197.20% vs sectorBetter
GNTLF
200.00%
avg
2.80%
5Y Dividend CAGR▼-6.80% vs sectorBelow avg
GNTLF
0.00%
avg
6.80%
Payout Ratio▲-5.00% vs sectorBetter
GNTLF
50.00%
avg
55.00%
Benchmarks: S&P 500 sector averages (2024–2026). Sources: Morningstar, Bloomberg, NAREIT. 5Y CAGR for GNTLF sourced from FMP /financial-growth endpoint — real data, not estimates.
🏛️ GNTLF Insider Activity
No recent SEC filings reported in the last 90 days.
🔬
Financial Health Scores
Altman Z-Score
135.31
✅ Safe Zone — low bankruptcy risk
Safe: >3.0 · Grey: 1.81–3.0 · Distress: <1.81
Piotroski F-Score
3/9
🔴 Weak fundamentals — dividend safety concern
Strong: 7–9 · Moderate: 4–6 · Weak: 0–3
Altman Z-Score predicts bankruptcy risk. Piotroski F-Score measures financial strength across 9 criteria. High scores → lower dividend cut risk. Data via FMP financial statements.
📊 About This Data
Dividend yields, payout ratios, and financial metrics are sourced from Financial Modeling Prep (FMP) and cross-referenced with SEC EDGAR filings. Data is cached and updated every 24 hours via our nightly refresh. DRIP projections are forward-looking estimates, not guarantees.
Educational purposes only. Not financial advice. DividendFlow is not a registered investment advisor. Projections generated by the GNTLF dividend calculator are estimates based on historical data and user inputs. Actual future returns, stock prices, and dividend payments will vary. Dividends can be cut or suspended at any time. All investments carry risk, including the loss of principal. Please consult a qualified financial professional before making any investment decisions. Full disclaimer →